Chemokine Receptor Signaling and the Hallmarks of Cancer

International Review of Cell and Molecular Biology

Volumn 331, Issue , 2017, Pages 181-244

  Lacalle, R A ^a   Blanco, R ^a   Carmona Rodriguez L ^a   Martin Leal A ^a   Mira, E ^a   Manes S ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Angiogenesis; Antitumor immune response; Apoptosis; Cancer stem cells; Chemokines; Proliferation; Receptor; Senescence

Indexed keywords

CHEMOKINE RECEPTOR; LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER STEM CELL; CARCINOGENESIS; CELL INFILTRATION; CELL PLASTICITY; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; IMMUNOCOMPETENT CELL; MALIGNANT NEOPLASM; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOLID MALIGNANT NEOPLASM; STROMA CELL; SYSTEMATIC REVIEW (TOPIC); TUMOR CELL; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; MULTIGENE FAMILY; NEOPLASM;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NEOPLASMS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 85007432870     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.09.011     Document Type: Chapter

References (327)

1. Acosta, J.C., Gil, J., A role for CXCR2 in senescence, but what about in cancer?. Cancer Res. 69 (2009), 2167–2170.
2. Adams, J.M., Cory, S., Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19 (2007), 488–496.
3. Ahn, G.O., Brown, J.M., Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Angiogenesis 12 (2009), 159–164.
4. Allen, S.J., Crown, S.E., Handel, T.M., Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007), 787–820.
5. Amersi, F.F., Terando, A.M., Goto, Y., Scolyer, R.A., Thompson, J.F., Tran, A.N., Faries, M.B., Morton, D.L., Hoon, D.S., Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin. Cancer Res. 14 (2008), 638–645.
6. Andres, G., Leali, D., Mitola, S., Coltrini, D., Camozzi, M., Corsini, M., Belleri, M., Hirsch, E., Schwendener, R.A., Christofori, G., Alcami, A., Presta, M., A pro-inflammatory signature mediates FGF2-induced angiogenesis. J. Cell. Mol. Med. 13 (2009), 2083–2108.
7. Andrew, D.P., Ruffing, N., Kim, C.H., Miao, W., Heath, H., Li, Y., Murphy, K., Campbell, J.J., Butcher, E.C., Wu, L., C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J. Immunol. 166 (2001), 103–111.
8. Anz, D., Rapp, M., Eiber, S., Koelzer, V.H., Thaler, R., Haubner, S., Knott, M., Nagel, S., Golic, M., Wiedemann, G.M., Bauernfeind, F., Wurzenberger, C., Hornung, V., Scholz, C., Mayr, D., Rothenfusser, S., Endres, S., Bourquin, C., Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. Cancer Res. 75 (2015), 4483–4493.
9. Aplin, A.C., Fogel, E., Nicosia, R.F., MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model. Angiogenesis 13 (2010), 219–226.
10. Arai, H., Tsou, C.L., Charo, I.F., Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 14495–14499.
11. Asperti-Boursin, F., Real, E., Bismuth, G., Trautmann, A., Donnadieu, E., CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3-kinase-independent manner. J. Exp. Med. 204 (2007), 1167–1179.
12. Bachelerie, F., CXCL12/CXCR4-axis dysfunctions: markers of the rare immunodeficiency disorder WHIM syndrome. Dis. Markers 29 (2010), 189–198.
13. Bachelerie, F., Graham, G.J., Locati, M., Mantovani, A., Murphy, P.M., Nibbs, R., Rot, A., Sozzani, S., Thelen, M., An atypical addition to the chemokine receptor nomenclature: IUPHAR review 15. Br. J. Pharmacol. 172 (2015), 3945–3949.
14. Bacon, K.B., Szabo, M.C., Yssel, H., Bolen, J.B., Schall, T.J., RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J. Exp. Med. 184 (1996), 873–882.
15. Bacon, K., Baggiolini, M., Broxmeyer, H., Horuk, R., Lindley, I., Mantovani, A., Maysushima, K., Murphy, P., Nomiyama, H., Oppenheim, J., Rot, A., Schall, T., Tsang, M., Thorpe, R., Van Damme, J., Wadhwa, M., Yoshie, O., Zlotnik, A., Zoon, K., Nomenclature, I.W.S.O.C., Chemokine/chemokine receptor nomenclature. J. Interferon Cytokine Res. 22 (2002), 1067–1068.
16. Balan, M., Pal, S., A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation. J. Biol. Chem. 289 (2014), 3126–3137.
17. Barreira Da Silva, R., Laird, M.E., Yatim, N., Fiette, L., Ingersoll, M.A., Albert, M.L., Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat. Immunol. 16 (2015), 850–858.
18. Ben-Porath, I., Thomson, M.W., Carey, V.J., Ge, R., Bell, G.W., Regev, A., Weinberg, R.A., An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40 (2008), 499–507.
19. Bertolini, G., D'amico, L., Moro, M., Landoni, E., Perego, P., Miceli, R., Gatti, L., Andriani, F., Wong, D., Caserini, R., Tortoreto, M., Milione, M., Ferracini, R., Mariani, L., Pastorino, U., Roato, I., Sozzi, G., Roz, L., Microenvironment-modulated metastatic CD133 +/CXCR4 +/EpCAM- lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis. Cancer Res. 75 (2015), 3636–3649.
20. Bertran, E., Caja, L., Navarro, E., Sancho, P., Mainez, J., Murillo, M.M., Vinyals, A., Fabra, A., Fabregat, I., Role of CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-beta. Cell. Signal. 21 (2009), 1595–1606.
21. Bindea, G., Mlecnik, B., Angell, H.K., Galon, J., The immune landscape of human tumors: implications for cancer immunotherapy. OncoImmunology, 3, 2014, e27456.
22. Bolitho, C., Hahn, M.A., Baxter, R.C., Marsh, D.J., The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocr. Relat. Cancer 17 (2010), 929–940.
23. Bolos, V., Mira, E., Martinez-Poveda, B., Luxan, G., Canamero, M., Martinez, A.C., Manes, S., De La Pompa, J.L., Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res., 15, 2013, R54.
24. Bonacchi, A., Romagnani, P., Romanelli, R.G., Efsen, E., Annunziato, F., Lasagni, L., Francalanci, M., Serio, M., Laffi, G., Pinzani, M., Gentilini, P., Marra, F., Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 276 (2001), 9945–9954.
25. Bonnet, D., Dick, J.E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997), 730–737.
26. Borrello, M.G., Alberti, L., Fischer, A., Degl'innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., Pilotti, S., Cassinelli, G., Bressan, P., Fugazzola, L., Mantovani, A., Pierotti, M.A., Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 14825–14830.
27. Borst, O., Munzer, P., Gatidis, S., Schmidt, E.M., Schonberger, T., Schmid, E., Towhid, S.T., Stellos, K., Seizer, P., May, A.E., Lang, F., Gawaz, M., The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ. Res. 111 (2012), 1297–1307.
28. Boyle, S.T., Ingman, W.V., Poltavets, V., Faulkner, J.W., Whitfield, R.J., Mccoll, S.R., Kochetkova, M., The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Oncogene 35 (2016), 105–115.
29. Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'aquila, M., Kipps, T.J., Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96 (2000), 2655–2663.
30. Burnet, F.M., The concept of immunological surveillance. Prog. Exp. Tumor Res. 13 (1970), 1–27.
31. Cabrera, M.C., Hollingsworth, R.E., Hurt, E.M., Cancer stem cell plasticity and tumor hierarchy. World J. Stem Cells 7 (2015), 27–36.
32. Camargo, J.F., Quinones, M.P., Mummidi, S., Srinivas, S., Gaitan, A.A., Begum, K., Jimenez, F., Vancompernolle, S., Unutmaz, D., Ahuja, S.S., Ahuja, S.K., CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. J. Immunol. 182 (2009), 171–182.
33. Carmeliet, P., Jain, R.K., Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10 (2011), 417–427.
34. Carretero, R., Sektioglu, I.M., Garbi, N., Salgado, O.C., Beckhove, P., Hammerling, G.J., Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells. Nat. Immunol. 16 (2015), 609–617.
35. Cascio, G., Martin-Cofreces, N.B., Rodriguez-Frade, J.M., Lopez-Cotarelo, P., Criado, G., Pablos, J.L., Rodriguez-Fernandez, J.L., Sanchez-Madrid, F., Mellado, M., CXCL12 regulates through JAK1 and JAK2 formation of productive immunological synapses. J. Immunol. 194 (2015), 5509–5519.
36. Castellino, F., Huang, A.Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., Germain, R.N., Chemokines enhance immunity by guiding naive CD8 + T cells to sites of CD4 + T cell-dendritic cell interaction. Nature 440 (2006), 890–895.
37. Ceradini, D.J., Gurtner, G.C., Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 15 (2005), 57–63.
38. Chang, L.Y., Lin, Y.C., Mahalingam, J., Huang, C.T., Chen, T.W., Kang, C.W., Peng, H.M., Chu, Y.Y., Chiang, J.M., Dutta, A., Day, Y.J., Chen, T.C., Yeh, C.T., Lin, C.Y., Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res. 72 (2012), 1092–1102.
39. Chang, D.K., Peterson, E., Sun, J., Goudie, C., Drapkin, R.I., Liu, J.F., Matulonis, U., Zhu, Q., Marasco, W.A., Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model. OncoImmunology, 5, 2016, e1090075.
40. Chen, H.J., Edwards, R., Tucci, S., Bu, P., Milsom, J., Lee, S., Edelmann, W., Gumus, Z.H., Shen, X., Lipkin, S., Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J. Clin. Invest. 122 (2012), 3184–3196.
41. Chen, T., Margariti, A., Kelaini, S., Cochrane, A., Guha, S.T., Hu, Y., Stitt, A.W., Zhang, L., Xu, Q., MicroRNA-199b modulates vascular cell fate during iPS cell differentiation by targeting the Notch ligand Jagged1 and enhancing VEGF signaling. Stem Cells 33 (2015), 1405–1418.
42. Cheng, Z.J., Zhao, J., Sun, Y., Hu, W., Wu, Y.L., Cen, B., Wu, G.X., Pei, G., Beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4. J. Biol. Chem. 275 (2000), 2479–2485.
43. Chun, E., Lavoie, S., Michaud, M., Gallini, C.A., Kim, J., Soucy, G., Odze, R., Glickman, J.N., Garrett, W.S., CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function. Cell Rep. 12 (2015), 244–257.
44. Clore, G.M., Appella, E., Yamada, M., Matsushima, K., Gronenborn, A.M., Three-dimensional structure of interleukin 8 in solution. Biochemistry 29 (1990), 1689–1696.
45. Comerford, I., Kara, E.E., Mckenzie, D.R., Mccoll, S.R., Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking. Br. J. Haematol. 164 (2014), 329–341.
46. Contento, R.L., Molon, B., Boularan, C., Pozzan, T., Mañes, S., Marullo, S., Viola, A., CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 10101–10106.
47. Crown, S.E., Yu, Y., Sweeney, M.D., Leary, J.A., Handel, T.M., Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J. Biol. Chem. 281 (2006), 25438–25446.
48. Cunningham, H.D., Shannon, L.A., Calloway, P.A., Fassold, B.C., Dunwiddie, I., Vielhauer, G., Zhang, M., Vines, C.M., Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Transl. Oncol. 3 (2010), 354–361.
49. Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M.L., Knutson, K.L., Chen, L., Zou, W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (2004), 942–949.
50. Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., Peled, A., Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18 (2004), 1240–1242.
51. Datar, I., Qiu, X., Ma, H.Z., Yeung, M., Aras, S., De La Serna, I., Al-Mulla, F., Thiery, J.P., Trumbly, R., Fan, X., Cui, H., Yeung, K.C., RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration. Oncotarget 6 (2015), 39050–39061.
52. Datta, D., Flaxenburg, J.A., Laxmanan, S., Geehan, C., Grimm, M., Waaga-Gasser, A.M., Briscoe, D.M., Pal, S., Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res. 66 (2006), 9509–9518.
53. De Falco, E., Porcelli, D., Torella, A.R., Straino, S., Iachininoto, M.G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M.C., Pesce, M., SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 (2004), 3472–3482.
54. De Sanctis, F., Sandri, S., Ferrarini, G., Pagliarello, I., Sartoris, S., Ugel, S., Marigo, I., Molon, B., Bronte, V., The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment. Front. Immunol., 5, 2014, 69.
55. Deutsch, E., Johnson, S.A., Seegers, W.H., Differentiation of certain platelet factors related to blood coagulation. Circ. Res. 3 (1955), 110–115.
56. Devalaraja, M.N., Richmond, A., Multiple chemotactic factors: fine control or redundancy?. Trends Pharmacol. Sci. 20 (1999), 151–156.
57. Draghiciu, O., Lubbers, J., Nijman, H.W., Daemen, T., Myeloid derived suppressor cells—an overview of combat strategies to increase immunotherapy efficacy. OncoImmunology, 4, 2015, e954829.
58. Duckworth, C., Zhang, L., Carroll, S.L., Ethier, S.P., Cheung, H.W., Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene 35 (2016), 4036–4047, 10.1038/onc.2015.472.
59. Dudek, A.Z., Nesmelova, I., Mayo, K., Verfaillie, C.M., Pitchford, S., Slungaard, A., Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. Blood 101 (2003), 4687–4694.
60. Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., Schreiber, R.D., Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3 (2002), 991–998.
61. Fabbri, E., Brognara, E., Montagner, G., Ghimenton, C., Eccher, A., Cantu, C., Khalil, S., Bezzerri, V., Provezza, L., Bianchi, N., Finotti, A., Borgatti, M., Moretto, G., Chilosi, M., Cabrini, G., Gambari, R., Regulation of IL-8 gene expression in gliomas by microRNA miR-93. BMC Cancer, 15, 2015, 661.
62. Fernando, R.I., Castillo, M.D., Litzinger, M., Hamilton, D.H., Palena, C., IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 71 (2011), 5296–5306.
63. Forster, R., Davalos-Misslitz, A.C., Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8 (2008), 362–371.
64. Franciszkiewicz, K., Le Floc'h, A., Jalil, A., Vigant, F., Robert, T., Vergnon, I., Mackiewicz, A., Benihoud, K., Validire, P., Chouaib, S., Combadiere, C., Mami-Chouaib, F., Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res. 69 (2009), 6249–6255.
65. Friedman, R.S., Jacobelli, J., Krummel, M.F., Surface-bound chemokines capture and prime T cells for synapse formation. Nat. Immunol. 7 (2006), 1101–1108.
66. Gadina, M., Hilton, D., Johnston, J.A., Morinobu, A., Lighvani, A., Zhou, Y.J., Visconti, R., O'shea, J.J., Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13 (2001), 363–373.
67. Galluzzi, L., Pietrocola, F., Bravo-San Pedro, J.M., Amaravadi, R.K., Baehrecke, E.H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D.A., Karantza, V., Kimmelman, A., Kumar, S., Levine, B., Maiuri, M.C., Martin, S.J., Penninger, J., Piacentini, M., Rubinsztein, D.C., Simon, H.U., Simonsen, A., Thorburn, A.M., Velasco, G., Ryan, K.M., Kroemer, G., Autophagy in malignant transformation and cancer progression. EMBO J. 34 (2015), 856–880.
68. Gassenmaier, M., Chen, D., Buchner, A., Henkel, L., Schiemann, M., Mack, B., Schendel, D.J., Zimmermann, W., Pohla, H., CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells 31 (2013), 1467–1476.
69. Gatti, M., Pattarozzi, A., Bajetto, A., Wurth, R., Daga, A., Fiaschi, P., Zona, G., Florio, T., Barbieri, F., Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology 314 (2013), 209–220.
70. Gattinoni, L., Klebanoff, C.A., Palmer, D.C., Wrzesinski, C., Kerstann, K., Yu, Z., Finkelstein, S.E., Theoret, M.R., Rosenberg, S.A., Restifo, N.P., Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8 + T cells. J. Clin. Invest. 115 (2005), 1616–1626.
71. Gavard, J., Hou, X., Qu, Y., Masedunskas, A., Martin, D., Weigert, R., Li, X., Gutkind, J.S., A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol. Cell. Biol. 29 (2009), 2469–2480.
72. Ghadjar, P., Rubie, C., Aebersold, D.M., Keilholz, U., The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 125 (2009), 741–745.
73. Ginestier, C., Liu, S., Diebel, M.E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., Guan, J.L., Dontu, G., Wicha, M.S., CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 120 (2010), 485–497.
74. Goel, S., Duda, D.G., Xu, L., Munn, L.L., Boucher, Y., Fukumura, D., Jain, R.K., Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91 (2011), 1071–1121.
75. Gollmer, K., Asperti-Boursin, F., Tanaka, Y., Okkenhaug, K., Vanhaesebroeck, B., Peterson, J.R., Fukui, Y., Donnadieu, E., Stein, J.V., CCL21 mediates CD4 + T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood 114 (2009), 580–588.
76. Gomez-Mouton, C., Mañes, S., Establishment and maintenance of cell polarity during leukocyte chemotaxis. Cell Adh. Migr. 1 (2007), 69–76.
77. Gomez-Mouton, C., Abad, J.L., Mira, E., Lacalle, R.A., Gallardo, E., Jimenez-Baranda, S., Illa, I., Bernad, A., Mañes, S., Martinez, A.C., Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. U.S.A. 98 (2001), 9642–9647.
78. Gomez-Mouton, C., Lacalle, R.A., Mira, E., Jimenez-Baranda, S., Barber, D.F., Carrera, A.C., Martinez, A.C., Mañes, S., Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J. Cell Biol. 164 (2004), 759–768.
79. Gómez-Moutón, C., Fischer, T., Peregil, R.M., Jiménez-Baranda, S., Stossel, T.P., Nakamura, F., Mañes, S., Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors. Blood 125 (2015), 1116–1125.
80. Gong, J.H., Clark-Lewis, I., Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J. Exp. Med. 181 (1995), 631–640.
81. Gonzalez-Martin, A., Gomez, L., Lustgarten, J., Mira, E., Mañes, S., Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells. Cancer Res. 71 (2011), 5455–5466.
82. Gonzalez-Martin, A., Mira, E., Mañes, S., CCR5 as a potential target in cancer therapy: inhibition or stimulation?. Anticancer Agents Med. Chem. 12 (2012), 1045–1057.
83. Gonzalez-Martin, A., Mira, E., Mañes, S., CCR5 in cancer immunotherapy: more than an “attractive” receptor for T cells. OncoImmunology 1 (2012), 106–108.
84. Graham, G.J., Locati, M., Mantovani, A., Rot, A., Thelen, M., The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145 (2012), 30–38.
85. Guo, J., Wang, B., Zhang, M., Chen, T., Yu, Y., Regulier, E., Homann, H.E., Qin, Z., Ju, D.W., Cao, X., Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther. 9 (2002), 793–803.
86. Guo, X., Oshima, H., Kitmura, T., Taketo, M.M., Oshima, M., Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem. 283 (2008), 19864–19871.
87. Guo, H., Liu, Z., Xu, B., Hu, H., Wei, Z., Liu, Q., Zhang, X., Ding, X., Wang, Y., Zhao, M., Gong, Y., Shao, C., Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage. Aging Cell 12 (2013), 1110–1121.
88. Gupta, S.C., Sundaram, C., Reuter, S., Aggarwal, B.B., Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta 1799 (2010), 775–787.
89. Halama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., Lerchl, T., Luckner-Minden, C., Ulrich, A., Koch, M., Weitz, J., Schneider, M., Buechler, M.W., Zitvogel, L., Herrmann, T., Benner, A., Kunz, C., Luecke, S., Springfeld, C., Grabe, N., Falk, C.S., Jaeger, D., Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell 29 (2016), 587–601.
90. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
91. Hashimoto, I., Koizumi, K., Tatematsu, M., Minami, T., Cho, S., Takeno, N., Nakashima, A., Sakurai, H., Saito, S., Tsukada, K., Saiki, I., Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur. J. Cancer 44 (2008), 1022–1029.
92. Haskell, C.A., Cleary, M.D., Charo, I.F., Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J. Biol. Chem. 274 (1999), 10053–10058.
93. Heidarieh, H., Hernaez, B., Alcami, A., Immune modulation by virus-encoded secreted chemokine binding proteins. Virus Res. 209 (2015), 67–75.
94. Hensbergen, P.J., Wijnands, P.G., Schreurs, M.W., Scheper, R.J., Willemze, R., Tensen, C.P., The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8 + T lymphocytes but not inhibition of angiogenesis. J. Immunother. 28 (2005), 343–351.
95. Hernandez, P.A., Gorlin, R.J., Lukens, J.N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M.E., Diaz, G.A., Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34 (2003), 70–74.
96. Hernanz-Falcon, P., Rodriguez-Frade, J.M., Serrano, A., Juan, D., Del Sol, A., Soriano, S.F., Roncal, F., Gomez, L., Valencia, A., Martinez, A.C., Mellado, M., Identification of amino acid residues crucial for chemokine receptor dimerization. Nat. Immunol. 5 (2004), 216–223.
97. Hiratsuka, S., Watanabe, A., Aburatani, H., Maru, Y., Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8 (2006), 1369–1375.
98. Hirsch, E., Katanaev, V.L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., Wymann, M.P., Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 (2000), 1049–1053.
99. Hu, T.H., Yao, Y., Yu, S., Han, L.L., Wang, W.J., Guo, H., Tian, T., Ruan, Z.P., Kang, X.M., Wang, J., Wang, S.H., Nan, K.J., SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/beta-catenin signaling pathway. Cancer Lett. 354 (2014), 417–426.
100. Hugues, S., Scholer, A., Boissonnas, A., Nussbaum, A., Combadiere, C., Amigorena, S., Fetler, L., Dynamic imaging of chemokine-dependent CD8 + T cell help for CD8 + T cell responses. Nat. Immunol. 8 (2007), 921–930.
101. Hundhausen, C., Schulte, A., Schulz, B., Andrzejewski, M.G., Schwarz, N., Von Hundelshausen, P., Winter, U., Paliga, K., Reiss, K., Saftig, P., Weber, C., Ludwig, A., Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J. Immunol. 178 (2007), 8064–8072.
102. Hwang, J., Kim, C.W., Son, K.N., Han, K.Y., Lee, K.H., Kleinman, H.K., Ko, J., Na, D.S., Kwon, B.S., Gho, Y.S., Kim, J., Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 570 (2004), 47–51.
103. Hwang, J., Son, K.N., Kim, C.W., Ko, J., Na, D.S., Kwon, B.S., Gho, Y.S., Kim, J., Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30 (2005), 254–263.
104. Hwang, W.L., Yang, M.H., Tsai, M.L., Lan, H.Y., Su, S.H., Chang, S.C., Teng, H.W., Yang, S.H., Lan, Y.T., Chiou, S.H., Wang, H.W., SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141 (2011), 279–291 e271–275.
105. Ierano, C., Santagata, S., Napolitano, M., Guardia, F., Grimaldi, A., Antignani, E., Botti, G., Consales, C., Riccio, A., Nanayakkara, M., Barone, M.V., Caraglia, M., Scala, S., CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. Cell Death Dis., 5, 2014, e1310.
106. Iotti, G., Ferrari-Amorotti, G., Rosafio, C., Corradini, F., Lidonnici, M.R., Ronchetti, M., Bardini, M., Zhang, Y., Martinez, R., Blasi, F., Calabretta, B., Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells. Oncogene 26 (2007), 3482–3491.
107. Ishida, T., Utsunomiya, A., Iida, S., Inagaki, H., Takatsuka, Y., Kusumoto, S., Takeuchi, G., Shimizu, S., Ito, M., Komatsu, H., Wakita, A., Eimoto, T., Matsushima, K., Ueda, R., Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin. Cancer Res. 9 (2003), 3625–3634.
108. Izumi, K., Fang, L.Y., Mizokami, A., Namiki, M., Li, L., Lin, W.J., Chang, C., Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol. Med. 5 (2013), 1383–1401.
109. Jarnagin, K., Grunberger, D., Mulkins, M., Wong, B., Hemmerich, S., Paavola, C., Bloom, A., Bhakta, S., Diehl, F., Freedman, R., Mccarley, D., Polsky, I., Ping-Tsou, A., Kosaka, A., Handel, T.M., Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry 38 (1999), 16167–16177.
110. Jiménez-Baranda, S., Gómez-Moutón, C., Rojas, A., Martínez-Prats, L., Mira, E., Lacalle, R.A., Valencia, A., Dimitrov, D.S., Viola, A., Delgado, R., Martínez, A.C., Mañes, S., Filamin-A regulates actin-dependent clustering of HIV receptors. Nat. Cell Biol. 9 (2007), 838–846.
111. Jo, H., Zhang, R., Zhang, H., Mckinsey, T.A., Shao, J., Beauchamp, R.D., Ballard, D.W., Liang, P., NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene 19 (2000), 841–849.
112. Johansson-Lindbom, B., Agace, W.W., Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev. 215 (2007), 226–242.
113. Johnson-Holiday, C., Singh, R., Johnson, E., Singh, S., Stockard, C.R., Grizzle, W.E., Lillard, J.W. Jr., CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int. J. Oncol. 38 (2011), 1279–1285.
114. Jordan-Sciutto, K.L., Murray Fenner, B.A., Wiley, C.A., Achim, C.L., Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp. Neurol. 167 (2001), 205–214.
115. Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., Richardson, A.L., Polyak, K., Tubo, R., Weinberg, R.A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007), 557–563.
116. Kehlen, A., Greither, T., Wach, S., Nolte, E., Kappler, M., Bache, M., Holzhausen, H.J., Lautenschlager, C., Gobel, S., Wurl, P., Immel, U.D., Agaimy, A., Wullich, B., Taubert, H., High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients. Int. J. Cancer 135 (2014), 2096–2106.
117. Kelly, G.L., Strasser, A., The essential role of evasion from cell death in cancer. Adv. Cancer Res. 111 (2011), 39–96.
118. Kim, K.S., Rajarathnam, K., Clark-Lewis, I., Sykes, B.D., Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395 (1996), 277–282.
119. Kim, J.W., Ferris, R.L., Whiteside, T.L., Chemokine C receptor 7 expression and protection of circulating CD8 + T lymphocytes from apoptosis. Clin. Cancer Res. 11 (2005), 7901–7910.
120. Koch, M.A., Tucker-Heard, G., Perdue, N.R., Killebrew, J.R., Urdahl, K.B., Campbell, D.J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10 (2009), 595–602.
121. Kondo, Y., Kanzawa, T., Sawaya, R., Kondo, S., The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 5 (2005), 726–734.
122. Kremer, K.N., Peterson, K.L., Schneider, P.A., Meng, X.W., Dai, H., Hess, A.D., Smith, B.D., Rodriguez-Ramirez, C., Karp, J.E., Kaufmann, S.H., Hedin, K.E., CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak. J. Biol. Chem. 288 (2013), 22899–22914.
123. Kumar, A., Humphreys, T.D., Kremer, K.N., Bramati, P.S., Bradfield, L., Edgar, C.E., Hedin, K.E., CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 25 (2006), 213–224.
124. Lagane, B., Chow, K.Y., Balabanian, K., Levoye, A., Harriague, J., Planchenault, T., Baleux, F., Gunera-Saad, N., Arenzana-Seisdedos, F., Bachelerie, F., CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 112 (2008), 34–44.
125. Lanca, T., Costa, M.F., Goncalves-Sousa, N., Rei, M., Grosso, A.R., Penido, C., Silva-Santos, B., Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds. J. Immunol. 190 (2013), 6673–6680.
126. Larue, L., Bellacosa, A., Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24 (2005), 7443–7454.
127. Lau, E.K., Paavola, C.D., Johnson, Z., Gaudry, J.P., Geretti, E., Borlat, F., Kungl, A.J., Proudfoot, A.E., Handel, T.M., Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279 (2004), 22294–22305.
128. Laurence, J.S., Blanpain, C., Burgner, J.W., Parmentier, M., Liwang, P.J., CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39 (2000), 3401–3409.
129. Lavergne, E., Combadiere, C., Iga, M., Boissonnas, A., Bonduelle, O., Maho, M., Debre, P., Combadiere, B., Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J. Immunol. 173 (2004), 3755–3762.
130. Lay, A.J., Jiang, X.M., Kisker, O., Flynn, E., Underwood, A., Condron, R., Hogg, P.J., Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature 408 (2000), 869–873.
131. Lee, N.J., Choi, D.Y., Song, J.K., Jung, Y.Y., Kim, D.H., Kim, T.M., Kim, D.J., Kwon, S.M., Kim, K.B., Choi, K.E., Moon, D.C., Kim, Y., Han, S.B., Hong, J.T., Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model. Carcinogenesis 33 (2012), 2520–2528.
132. Lee, W.Y., Wang, C.J., Lin, T.Y., Hsiao, C.L., Luo, C.W., CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. Am. J. Physiol. Endocrinol. Metab. 304 (2013), E32–E40.
133. Lee, E., Fertig, E.J., Jin, K., Sukumar, S., Pandey, N.B., Popel, A.S., Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat. Commun., 5, 2014, 4715.
134. Li, Y.M., Pan, Y., Wei, Y., Cheng, X., Zhou, B.P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G.N., Yu, D., Hung, M.C., Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6 (2004), 459–469.
135. Li, X., Ma, Q., Xu, Q., Liu, H., Lei, J., Duan, W., Bhat, K., Wang, F., Wu, E., Wang, Z., SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett. 322 (2012), 169–176.
136. Li, M., Knight, D.A., A Snyder, L., Smyth, M.J., Stewart, T.J., A role for CCL2 in both tumor progression and immunosurveillance. OncoImmunology, 2, 2013, e25474.
137. Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., Shim, H., CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun. 359 (2007), 716–722.
138. Liang, S., Peng, X., Li, X., Yang, P., Xie, L., Li, Y., Du, C., Zhang, G., Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. Oncotarget 6 (2015), 1020–1030.
139. Liao, Y.Y., Tsai, H.C., Chou, P.Y., Wang, S.W., Chen, H.T., Lin, Y.M., Chiang, I.P., Chang, T.M., Hsu, S.K., Chou, M.C., Tang, C.H., Fong, Y.C., CCL3 promotes angiogenesis by dysregulation of miR-374b/VEGF-A axis in human osteosarcoma cells. Oncotarget 7 (2016), 4310–4325.
140. Lim, J.Y., Gerber, S.A., Murphy, S.P., Lord, E.M., Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells. Cancer Immunol. Immunother. 63 (2014), 259–271.
141. Liu, J., Zhang, N., Li, Q., Zhang, W., Ke, F., Leng, Q., Wang, H., Chen, J., Wang, H., Tumor-associated macrophages recruit CCR6 + regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One, 6, 2011, e19495.
142. Liu, S., Ginestier, C., Ou, S.J., Clouthier, S.G., Patel, S.H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C.G., Jung, Y., Dontu, G., Taichman, R., Wicha, M.S., Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71 (2011), 614–624.
143. Liu, Q., Chen, H., Ojode, T., Gao, X., Anaya-O'brien, S., Turner, N.A., Ulrick, J., Decastro, R., Kelly, C., Cardones, A.R., Gold, S.H., Hwang, E.I., Wechsler, D.S., Malech, H.L., Murphy, P.M., Mcdermott, D.H., WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood 120 (2012), 181–189.
144. Liu, G.T., Chen, H.T., Tsou, H.K., Tan, T.W., Fong, Y.C., Chen, P.C., Yang, W.H., Wang, S.W., Chen, J.C., Tang, C.H., CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells. Oncotarget 5 (2014), 10718–10731.
145. Liu, G.T., Huang, Y.L., Tzeng, H.E., Tsai, C.H., Wang, S.W., Tang, C.H., CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Cancer Lett. 357 (2015), 476–487.
146. Liu, J., Li, F., Ping, Y., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S., Li, B., Kalinski, P., Thorne, S.H., Zhang, B., Zhang, Y., Local production of the chemokines CCL5 and CXCL10 attracts CD8 + T lymphocytes into esophageal squamous cell carcinoma. Oncotarget 6 (2015), 24978–24989.
147. Liu, J.Y., Li, F., Wang, L.P., Chen, X.F., Wang, D., Cao, L., Ping, Y., Zhao, S., Li, B., Thorne, S.H., Zhang, B., Kalinski, P., Zhang, Y., CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 113 (2015), 747–755.
148. Loberg, R.D., Ying, C., Craig, M., Day, L.L., Sargent, E., Neeley, C., Wojno, K., Snyder, L.A., Yan, L., Pienta, K.J., Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res. 67 (2007), 9417–9424.
149. Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., Zhu, B., Autocrine CCL5 signaling promotes invasion and migration of CD133 + ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells 30 (2012), 2309–2319.
150. Lopez-Giral, S., Quintana, N.E., Cabrerizo, M., Alfonso-Perez, M., Sala-Valdes, M., De Soria, V.G., Fernandez-Ranada, J.M., Fernandez-Ruiz, E., Munoz, C., Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J. Leukoc. Biol. 76 (2004), 462–471.
151. Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J.D., Strieter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K.N., Richmond, A., Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62 (1997), 588–597.
152. Lunardi, S., Jamieson, N.B., Lim, S.Y., Griffiths, K.L., Carvalho-Gaspar, M., Al-Assar, O., Yameen, S., Carter, R.C., Mckay, C.J., Spoletini, G., D'ugo, S., Silva, M.A., Sansom, O.J., Janssen, K.P., Muschel, R.J., Brunner, T.B., IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget 5 (2014), 11064–11080.
153. Lunardi, S., Lim, S.Y., Muschel, R.J., Brunner, T.B., IP-10/CXCL10 attracts regulatory T cells: implication for pancreatic cancer. OncoImmunology, 4, 2015, e1027473.
154. Luo, J., Lee, S.O., Cui, Y., Yang, R., Li, L., Chang, C., Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2alpha/androgen receptor signals. Oncotarget 6 (2015), 27555–27565.
155. Ma, J., Wang, Q., Fei, T., Han, J.D., Chen, Y.G., MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood 109 (2007), 987–994.
156. Ma, Y., Adjemian, S., Galluzzi, L., Zitvogel, L., Kroemer, G., Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. OncoImmunology, 3, 2014, e27663.
157. Ma, H., Gao, L., Li, S., Qin, J., Chen, L., Liu, X., Xu, P., Wang, F., Xiao, H., Zhou, S., Gao, Q., Liu, B., Sun, Y., Liang, C., CCR7 enhances TGF-beta1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer. Oncotarget 6 (2015), 24348–24360.
158. Mañes, S., Viola, A., Lipid rafts in lymphocyte activation and migration. Mol. Membr. Biol. 23 (2006), 59–69.
159. Mañes, S., Mira, E., Gomez-Mouton, C., Lacalle, R.A., Keller, P., Labrador, J.P., Martinez, A.C., Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18 (1999), 6211–6220.
160. Mañes, S., Lacalle, R.A., Gomez-Mouton, C., Del Real, G., Mira, E., Martinez, A.C., Membrane raft microdomains in chemokine receptor function. Semin. Immunol. 13 (2001), 147–157.
161. Mañes, S., Mira, E., Colomer, R., Montero, S., Real, L.M., Gomez-Mouton, C., Jimenez-Baranda, S., Garzon, A., Lacalle, R.A., Harshman, K., Ruiz, A., Martinez, A.C., CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J. Exp. Med. 198 (2003), 1381–1389.
162. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J., Weinberg, R.A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
163. Mantovani, A., The chemokine system: redundancy for robust outputs. Immunol. Today 20 (1999), 254–257.
164. Maravillas-Montero, J.L., Burkhardt, A.M., Hevezi, P.A., Carnevale, C.D., Smit, M.J., Zlotnik, A., Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17. J. Immunol. 194 (2015), 29–33.
165. Marchese, A., Trejo, J., Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling. Cell. Signal. 25 (2013), 707–716.
166. Marsigliante, S., Vetrugno, C., Muscella, A., CCL20 induces migration and proliferation on breast epithelial cells. J. Cell. Physiol. 228 (2013), 1873–1883.
167. Massara, M., Bonavita, O., Mantovani, A., Locati, M., Bonecchi, R., Atypical chemokine receptors in cancer: friends or foes?. J. Leukoc. Biol. 99 (2016), 927–933.
168. Matsushima, K., Larsen, C.G., Dubois, G.C., Oppenheim, J.J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169 (1989), 1485–1490.
169. Mcquibban, G.A., Gong, J.H., Wong, J.P., Wallace, J.L., Clark-Lewis, I., Overall, C.M., Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100 (2002), 1160–1167.
170. Mehta, S.A., Christopherson, K.W., Bhat-Nakshatri, P., Goulet, R.J. Jr., Broxmeyer, H.E., Kopelovich, L., Nakshatri, H., Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26 (2007), 3329–3337.
171. Melief, C.J., Cancer immunotherapy by dendritic cells. Immunity 29 (2008), 372–383.
172. Mellado, M., De Ana, A.M., Moreno, M.C., Martinez, C., Rodriguez-Frade, J.M., A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr. Biol. 11 (2001), 691–696.
173. Mellado, M., Rodriguez-Frade, J.M., Vila-Coro, A.J., Fernandez, S., Martin De Ana, A., Jones, D.R., Toran, J.L., Martinez, A.C., Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 20 (2001), 2497–2507.
174. Minsaas, L., Planaguma, J., Madziva, M., Krakstad, B.F., Masia-Balague, M., Katz, A.A., Aragay, A.M., Filamin a binds to CCR2B and regulates its internalization. PLoS One, 5, 2010, e12212.
175. Mionnet, C., Buatois, V., Kanda, A., Milcent, V., Fleury, S., Lair, D., Langelot, M., Lacoeuille, Y., Hessel, E., Coffman, R., Magnan, A., Dombrowicz, D., Glaichenhaus, N., Julia, V., CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat. Med. 16 (2010), 1305–1312.
176. Mira, E., Lacalle, R.A., Gonzalez, M.A., Gomez-Mouton, C., Abad, J.L., Bernad, A., Martinez, A.C., Manes, S., A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2 (2001), 151–156.
177. Mira, E., Lacalle, R.A., Buesa, J.M., De Buitrago, G.G., Jimenez-Baranda, S., Gomez-Mouton, C., Martinez, A.C., Manes, S., Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J. Cell Sci. 117 (2004), 1847–1857.
178. Mira, E., Carmona-Rodríguez, L., Tardáguila, M., Azcoitia, I., González-Martin, A., Almonacid, L., Casas, J., Fabriás, G., Mañes, S., A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors. Oncotarget 4 (2013), 2288–2301.
179. Mitkin, N.A., Hook, C.D., Schwartz, A.M., Biswas, S., Kochetkov, D.V., Muratova, A.M., Afanasyeva, M.A., Kravchenko, J.E., Bhattacharyya, A., Kuprash, D.V., p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells. Sci. Rep., 5, 2015, 9330.
180. Miyagaki, T., Sugaya, M., Murakami, T., Asano, Y., Tada, Y., Kadono, T., Okochi, H., Tamaki, K., Sato, S., CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Cancer Res. 71 (2011), 2056–2065.
181. Mizoue, L.S., Sullivan, S.K., King, D.S., Kledal, T.N., Schwartz, T.W., Bacon, K.B., Handel, T.M., Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine. J. Biol. Chem. 276 (2001), 33906–33914.
182. Mo, M., Zhou, M., Wang, L., Qi, L., Zhou, K., Liu, L.F., Chen, Z., Zu, X.B., CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells. PLoS One, 10, 2015, e0119506.
183. Molon, B., Gri, G., Bettella, M., Gomez-Mouton, C., Lanzavecchia, A., Martinez, A.C., Manes, S., Viola, A., T cell costimulation by chemokine receptors. Nat. Immunol. 6 (2005), 465–471.
184. Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., Savino, B., Colombo, P., Jonjic, N., Pecanic, S., Lazzarato, L., Fruttero, R., Gasco, A., Bronte, V., Viola, A., Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J. Exp. Med. 208 (2011), 1949–1962.
185. Monteclaro, F.S., Charo, I.F., The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 271 (1996), 19084–19092.
186. Moser, B., Willimann, K., Chemokines: role in inflammation and immune surveillance. Ann. Rheum. Dis. 63:Suppl. 2 (2004), ii84–ii89.
187. Mule, J.J., Custer, M., Averbook, B., Yang, J.C., Weber, J.S., Goeddel, D.V., Rosenberg, S.A., Schall, T.J., RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum. Gene Ther. 7 (1996), 1545–1553.
188. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., Mcclanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verastegui, E., Zlotnik, A., Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001), 50–56.
189. Murakami, T., Maki, W., Cardones, A.R., Fang, H., Tun Kyi, A., Nestle, F.O., Hwang, S.T., Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62 (2002), 7328–7334.
190. Murakami, T., Cardones, A.R., Finkelstein, S.E., Restifo, N.P., Klaunberg, B.A., Nestle, F.O., Castillo, S.S., Dennis, P.A., Hwang, S.T., Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J. Exp. Med. 198 (2003), 1337–1347.
191. Murooka, T.T., Wong, M.M., Rahbar, R., Majchrzak-Kita, B., Proudfoot, A.E., Fish, E.N., CCL5-CCR5-mediated apoptosis in T cells: requirement for glycosaminoglycan binding and CCL5 aggregation. J. Biol. Chem. 281 (2006), 25184–25194.
192. Murphy, P.M., The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12 (1994), 593–633.
193. Murphy, P.M., Viral chemokine receptors. Front. Immunol., 6, 2015, 281.
194. Murphy, P.M., Baggiolini, M., Charo, I.F., Hebert, C.A., Horuk, R., Matsushima, K., Miller, L.H., Oppenheim, J.J., Power, C.A., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000), 145–176.
195. Nesbeth, Y.C., Martinez, D.G., Toraya, S., Scarlett, U.K., Cubillos-Ruiz, J.R., Rutkowski, M.R., Conejo-Garcia, J.R., CD4 + T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. J. Immunol. 184 (2010), 5654–5662.
196. Nesmelova, I.V., Sham, Y., Dudek, A.Z., Van Eijk, L.I., Wu, G., Slungaard, A., Mortari, F., Griffioen, A.W., Mayo, K.H., Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level. J. Biol. Chem. 280 (2005), 4948–4958.
197. Nguyen, D.H., Taub, D., CXCR4 function requires membrane cholesterol: implications for HIV infection. J. Immunol. 168 (2002), 4121–4126.
198. Nolan, D.J., Ciarrocchi, A., Mellick, A.S., Jaggi, J.S., Bambino, K., Gupta, S., Heikamp, E., Mcdevitt, M.R., Scheinberg, D.A., Benezra, R., Mittal, V., Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 21 (2007), 1546–1558.
199. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 23–28.
200. Oghumu, S., Varikuti, S., Terrazas, C., Kotov, D., Nasser, M.W., Powell, C.A., Ganju, R.K., Satoskar, A.R., CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology 143 (2014), 109–119.
201. Okada, N., Gao, J.Q., Sasaki, A., Niwa, M., Okada, Y., Nakayama, T., Yoshie, O., Mizuguchi, H., Hayakawa, T., Fujita, T., Yamamoto, A., Tsutsumi, Y., Mayumi, T., Nakagawa, S., Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy. Biochem. Biophys. Res. Commun. 317 (2004), 68–76.
202. Olkhanud, P.B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R.L., Deng, J., Xu, M., Briest, S., Biragyn, A., Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res. 69 (2009), 5996–6004.
203. Pahler, J.C., Tazzyman, S., Erez, N., Chen, Y.Y., Murdoch, C., Nozawa, H., Lewis, C.E., Hanahan, D., Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 10 (2008), 329–340.
204. Pang, M.F., Georgoudaki, A.M., Lambut, L., Johansson, J., Tabor, V., Hagikura, K., Jin, Y., Jansson, M., Alexander, J.S., Nelson, C.M., Jakobsson, L., Betsholtz, C., Sund, M., Karlsson, M.C., Fuxe, J., TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene 35 (2016), 748–760.
205. Paoletti, S., Petkovic, V., Sebastiani, S., Danelon, M.G., Uguccioni, M., Gerber, B.O., A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105 (2005), 3405–3412.
206. Passaro, D., Irigoyen, M., Catherinet, C., Gachet, S., Da Costa De Jesus, C., Lasgi, C., Tran Quang, C., Ghysdael, J., CXCR4 is required for leukemia-initiating cell activity in T Cell Acute Lymphoblastic Leukemia. Cancer Cell 27 (2015), 769–779.
207. Peña, C.G., Nakada, Y., Saatcioglu, H.D., Aloisio, G.M., Cuevas, I., Zhang, S., Miller, D.S., Lea, J.S., Wong, K.K., Deberardinis, R.J., Amelio, A.L., Brekken, R.A., Castrillon, D.H., LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. J. Clin. Invest. 125 (2015), 4063–4076.
208. Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., Kotarski, J., Tarkowski, R., Dou, Y., Cho, K., Hensley-Alford, S., Munkarah, A., Liu, R., Zou, W., Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature 527 (2015), 249–253.
209. Pervaiz, A., Ansari, S., Berger, M.R., Adwan, H., CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells. Med. Oncol., 32, 2015, 158.
210. Phan-Lai, V., Kievit, F.M., Florczyk, S.J., Wang, K., Disis, M.L., Zhang, M., CCL21 and IFNgamma recruit and activate tumor specific T cells in 3D scaffold model of breast cancer. Anticancer Agents Med. Chem. 14 (2014), 204–210.
211. Ping, Y.F., Yao, X.H., Jiang, J.Y., Zhao, L.T., Yu, S.C., Jiang, T., Lin, M.C., Chen, J.H., Wang, B., Zhang, R., Cui, Y.H., Qian, C., Wang, J., Bian, X.W., The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J. Pathol. 224 (2011), 344–354.
212. Proost, P., Struyf, S., Couvreur, M., Lenaerts, J.P., Conings, R., Menten, P., Verhaert, P., Wuyts, A., Van Damme, J., Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J. Immunol. 160 (1998), 4034–4041.
213. Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A.M., Neyts, J., Liekens, S., Maudgal, P.C., Billiau, A., Van Damme, J., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98 (2001), 3554–3561.
214. Proost, P., Mortier, A., Loos, T., Vandercappellen, J., Gouwy, M., Ronsse, I., Schutyser, E., Put, W., Parmentier, M., Struyf, S., Van Damme, J., Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110 (2007), 37–44.
215. Proudfoot, A.E., Handel, T.M., Johnson, Z., Lau, E.K., Liwang, P., Clark-Lewis, I., Borlat, F., Wells, T.N., Kosco-Vilbois, M.H., Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 1885–1890.
216. Qiuping, Z., Jei, X., Youxin, J., Wei, J., Chun, L., Jin, W., Qun, W., Yan, L., Chunsong, H., Mingzhen, Y., Qingping, G., Kejian, Z., Zhimin, S., Qun, L., Junyan, L., Jinquan, T., CC chemokine ligand 25 enhances resistance to apoptosis in CD4 + T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation. Cancer Res. 64 (2004), 7579–7587.
217. Rabinowitz, J.D., White, E., Autophagy and metabolism. Science 330 (2010), 1344–1348.
218. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C.M., Gerard, N.P., Gerard, C., Lefkowitz, R.J., Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 628–632.
219. Rajendran, L., Simons, K., Lipid rafts and membrane dynamics. J. Cell Sci. 118 (2005), 1099–1102.
220. Raman, D., Baugher, P.J., Thu, Y.M., Richmond, A., Role of chemokines in tumor growth. Cancer Lett. 256 (2007), 137–165.
221. Reddy, K., Zhou, Z., Jia, S.F., Lee, T.H., Morales-Arias, J., Cao, Y., Kleinerman, E.S., Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int. J. Cancer 123 (2008), 831–837.
222. Repnik, U., Starr, A.E., Overall, C.M., Turk, B., Cysteine cathepsins activate ELR chemokines and inactivate non-ELR chemokines. J. Biol. Chem. 290 (2015), 13800–13811.
223. Ribas, C., Penela, P., Murga, C., Salcedo, A., Garcia-Hoz, C., Jurado-Pueyo, M., Aymerich, I., Mayor, F. Jr., The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim. Biophys. Acta 1768 (2007), 913–922.
224. Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E.A., Stassi, G., Larocca, L.M., De Maria, R., Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468 (2010), 824–828.
225. Robinson, S.C., Scott, K.A., Wilson, J.L., Thompson, R.G., Proudfoot, A.E., Balkwill, F.R., A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 63 (2003), 8360–8365.
226. Rodriguez-Frade, J.M., Mellado, M., Martinez, A.C., Chemokine receptor dimerization: two are better than one. Trends Immunol. 22 (2001), 612–617.
227. Rodriguez-Frade, J.M., Del Real, G., Serrano, A., Hernanz-Falcon, P., Soriano, S.F., Vila-Coro, A.J., De Ana, A.M., Lucas, P., Prieto, I., Martinez, A.C., Mellado, M., Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor. EMBO J. 23 (2004), 66–76.
228. Rollins, B.J., Sunday, M.E., Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11 (1991), 3125–3131.
229. Romain, B., Hachet-Haas, M., Rohr, S., Brigand, C., Galzi, J.L., Gaub, M.P., Pencreach, E., Guenot, D., Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol. Cancer, 13, 2014, 58.
230. Ruan, J.W., Liao, Y.C., Lua, I., Li, M.H., Hsu, C.Y., Chen, J.H., Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells. Breast Cancer Res., 14, 2012, R106.
231. Salanga, C.L., Dyer, D.P., Kiselar, J.G., Gupta, S., Chance, M.R., Handel, T.M., Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine. J. Biol. Chem. 289 (2014), 14896–14912.
232. Salazar, N., Muñoz, D., Kallifatidis, G., Singh, R.K., Jorda, M., Lokeshwar, B.L., The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation. Mol. Cancer, 13, 2014, 198.
233. Salcedo, R., Zhang, X., Young, H.A., Michael, N., Wasserman, K., Ma, W.H., Martins-Green, M., Murphy, W.J., Oppenheim, J.J., Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 102 (2003), 1966–1977.
234. Sanchez-Sanchez, N., Riol-Blanco, L., De La Rosa, G., Puig-Kroger, A., Garcia-Bordas, J., Martin, D., Longo, N., Cuadrado, A., Cabañas, C., Corbi, A.L., Sanchez-Mateos, P., Rodriguez-Fernandez, J.L., Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104 (2004), 619–625.
235. Sarvaiya, P.J., Guo, D., Ulasov, I., Gabikian, P., Lesniak, M.S., Chemokines in tumor progression and metastasis. Oncotarget 4 (2013), 2171–2185.
236. Sato, E., Olson, S.H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A.A., Frosina, D., Gnjatic, S., Ambrosone, C., Kepner, J., Odunsi, T., Ritter, G., Lele, S., Chen, Y.T., Ohtani, H., Old, L.J., Odunsi, K., Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 18538–18543.
237. Schmall, A., Al-Tamari, H.M., Herold, S., Kampschulte, M., Weigert, A., Wietelmann, A., Vipotnik, N., Grimminger, F., Seeger, W., Pullamsetti, S.S., Savai, R., Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. Am. J. Respir. Crit. Care Med. 191 (2015), 437–447.
238. Scholten, D.J., Canals, M., Maussang, D., Roumen, L., Smit, M.J., Wijtmans, M., De Graaf, C., Vischer, H.F., Leurs, R., Pharmacological modulation of chemokine receptor function. Br. J. Pharmacol. 165 (2012), 1617–1643.
239. Schulte, A., Schulz, B., Andrzejewski, M.G., Hundhausen, C., Mletzko, S., Achilles, J., Reiss, K., Paliga, K., Weber, C., John, S.R., Ludwig, A., Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem. Biophys. Res. Commun. 358 (2007), 233–240.
240. Semmling, V., Lukacs-Kornek, V., Thaiss, C.A., Quast, T., Hochheiser, K., Panzer, U., Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D.I., Savage, P.B., Knolle, P.A., Kolanus, W., Forster, I., Kurts, C., Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat. Immunol. 11 (2010), 313–320.
241. Shamas-Din, A., Brahmbhatt, H., Leber, B., Andrews, D.W., BH3-only proteins: orchestrators of apoptosis. Biochim. Biophys. Acta 1813 (2011), 508–520.
242. Shao, N., Chen, L.H., Ye, R.Y., Lin, Y., Wang, S.M., The depletion of interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells. Biochem. Biophys. Res. Commun. 431 (2013), 535–541.
243. Shen, H., Schuster, R., Stringer, K.F., Waltz, S.E., Lentsch, A.B., The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J. 20 (2006), 59–64.
244. Shi, G., Partida-Sanchez, S., Misra, R.S., Tighe, M., Borchers, M.T., Lee, J.J., Simon, M.I., Lund, F.E., Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J. Exp. Med. 204 (2007), 2705–2718.
245. Shields, J.D., Fleury, M.E., Yong, C., Tomei, A.A., Randolph, G.J., Swartz, M.A., Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11 (2007), 526–538.
246. Shields, J.D., Kourtis, I.C., Tomei, A.A., Roberts, J.M., Swartz, M.A., Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328 (2010), 749–752.
247. Shih, Y.T., Wang, M.C., Peng, H.H., Chen, T.F., Chen, L., Chang, J.Y., Chiu, J.J., Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma. Cell. Signal. 24 (2012), 779–793.
248. Shimizu, K., Mizuno, T., Shinga, J., Asakura, M., Kakimi, K., Ishii, Y., Masuda, K., Maeda, T., Sugahara, H., Sato, Y., Matsushita, H., Nishida, K., Hanada, K., Dorrie, J., Schaft, N., Bickham, K., Koike, H., Ando, T., Nagai, R., Fujii, S., Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells. Cancer Res. 73 (2013), 62–73.
249. Shiraishi, K., Fukuda, S., Mori, T., Matsuda, K., Yamaguchi, T., Tanikawa, C., Ogawa, M., Nakamura, Y., Arakawa, H., Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53. Cancer Res. 60 (2000), 3722–3726.
250. Simmons, G., Clapham, P.R., Picard, L., Offord, R.E., Rosenkilde, M.M., Schwartz, T.W., Buser, R., Wells, T.N., Proudfoot, A.E., Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276 (1997), 276–279.
251. Singh, R.K., Lokeshwar, B.L., The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res. 71 (2011), 3268–3277.
252. Singh, J.K., Farnie, G., Bundred, N.J., Simoes, B.M., Shergill, A., Landberg, G., Howell, S.J., Clarke, R.B., Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin. Cancer Res. 19 (2013), 643–656.
253. Smadja, D.M., Bieche, I., Uzan, G., Bompais, H., Muller, L., Boisson-Vidal, C., Vidaud, M., Aiach, M., Gaussem, P., PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2321–2327.
254. Smith, M.C., Luker, K.E., Garbow, J.R., Prior, J.L., Jackson, E., Piwnica-Worms, D., Luker, G.D., CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 64 (2004), 8604–8612.
255. Smith, X., Schneider, H., Kohler, K., Liu, H., Lu, Y., Rudd, C.E., The chemokine CXCL12 generates costimulatory signals in T cells to enhance phosphorylation and clustering of the adaptor protein SLP-76. Sci. Signal., 6, 2013, ra65.
256. Son, D.S., Kabir, S.M., Dong, Y.L., Lee, E., Adunyah, S.E., Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IkappaB. PLoS One, 7, 2012, e51116.
257. Song, L., Ara, T., Wu, H.W., Woo, C.W., Reynolds, C.P., Seeger, R.C., Declerck, Y.A., Thiele, C.J., Sposto, R., Metelitsa, L.S., Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J. Clin. Invest. 117 (2007), 2702–2712.
258. Song, J.K., Park, M.H., Choi, D.Y., Yoo, H.S., Han, S.B., Yoon Do, Y., Hong, J.T., Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and upregulation of IL-1Ra in melanoma model. PLoS One, 7, 2012, e33747.
259. Span, P.N., Pollakis, G., Paxton, W.A., Sweep, F.C., Foekens, J.A., Martens, J.W., Sieuwerts, A.M., Van Laarhoven, H.W., Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations. Int. J. Cancer 136 (2015), 91–97.
260. Spinetti, G., Bernardini, G., Camarda, G., Mangoni, A., Santoni, A., Capogrossi, M.C., Napolitano, M., The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway. J. Leukoc. Biol. 73 (2003), 201–207.
261. Springael, J.Y., Urizar, E., Parmentier, M., Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev. 16 (2005), 611–623.
262. Srivastava, A., Pandey, S.N., Choudhuri, G., Mittal, B., CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Scand. J. Immunol. 67 (2008), 516–522.
263. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E.J., Krek, W., Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425 (2003), 307–311.
264. Steen, A., Larsen, O., Thiele, S., Rosenkilde, M.M., Biased and g protein-independent signaling of chemokine receptors. Front. Immunol., 5, 2014, 277.
265. Stewart, T.J., Liewehr, D.J., Steinberg, S.M., Greeneltch, K.M., Abrams, S.I., Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1 + myeloid cells. J. Immunol. 183 (2009), 117–128.
266. Strasly, M., Doronzo, G., Cappello, P., Valdembri, D., Arese, M., Mitola, S., Moore, P., Alessandri, G., Giovarelli, M., Bussolino, F., CCL16 activates an angiogenic program in vascular endothelial cells. Blood 103 (2004), 40–49.
267. Strieter, R.M., Polverini, P.J., Kunkel, S.L., Arenberg, D.A., Burdick, M.D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270 (1995), 27348–27357.
268. Strieter, R.M., Burdick, M.D., Gomperts, B.N., Belperio, J.A., Keane, M.P., CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 16 (2005), 593–609.
269. Sun, Y., Cheng, Z., Ma, L., Pei, G., Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277 (2002), 49212–49219.
270. Suyama, T., Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., Ichikawa, T., Ueda, T., Nikaido, T., Ito, H., Ishikura, H., Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103 (2005), 258–267.
271. Takeuchi, H., Fujimoto, A., Tanaka, M., Yamano, T., Hsueh, E., Hoon, D.S., CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin. Cancer Res. 10 (2004), 2351–2358.
272. Tan, M.C., Goedegebuure, P.S., Belt, B.A., Flaherty, B., Sankpal, N., Gillanders, W.E., Eberlein, T.J., Hsieh, C.S., Linehan, D.C., Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J. Immunol. 182 (2009), 1746–1755.
273. Tang, W., Yu, F., Yao, H., Cui, X., Jiao, Y., Lin, L., Chen, J., Yin, D., Song, E., Liu, Q., miR-27a regulates endothelial differentiation of breast cancer stem like cells. Oncogene 33 (2014), 2629–2638.
274. Tang, S., Xiang, T., Huang, S., Zhou, J., Wang, Z., Xie, R., Long, H., Zhu, B., Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling. Cancer Lett. 376 (2016), 137–147.
275. Tardaguila, M., Mañes, S., CX3CL1 at the crossroad of EGF signals: relevance for the progression of ERBB2 breast carcinoma. OncoImmunology, 2, 2013, e25669.
276. Tardaguila, M., Mira, E., Garcia-Cabezas, M.A., Feijoo, A.M., Quintela-Fandino, M., Azcoitia, I., Lira, S.A., Mañes, S., CX3CL1 promotes breast cancer via transactivation of the EGF pathway. Cancer Res. 73 (2013), 4461–4473.
277. Thelen, M., Baggiolini, M., Is dimerization of chemokine receptors functionally relevant?. Sci. STKE, 2001, 2001, pe34.
278. Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002), 442–454.
279. Toh, B., Wang, X., Keeble, J., Sim, W.J., Khoo, K., Wong, W.C., Kato, M., Prevost-Blondel, A., Thiery, J.P., Abastado, J.P., Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol., 9, 2011, e1001162.
280. Trettel, F., Di Bartolomeo, S., Lauro, C., Catalano, M., Ciotti, M.T., Limatola, C., Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278 (2003), 40980–40988.
281. Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A.X., Wu, X., Ye, W., Chen, S., Zhou, W., Yu, Y., Wang, Y.Z., Ren, X., Li, H., Scherle, P., Kuroki, Y., Wang, S.E., CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 72 (2012), 2768–2779.
282. Uekusa, Y., Yu, W.G., Mukai, T., Gao, P., Yamaguchi, N., Murai, M., Matsushima, K., Obika, S., Imanishi, T., Higashibata, Y., Nomura, S., Kitamura, Y., Fujiwara, H., Hamaoka, T., A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice. Cancer Res. 62 (2002), 3751–3758.
283. Van Damme, J., Struyf, S., Opdenakker, G., Chemokine-protease interactions in cancer. Semin. Cancer Biol. 14 (2004), 201–208.
284. Van Deventer, H.W., Wu, Q.P., Bergstralh, D.T., Davis, B.K., O'connor, B.P., Ting, J.P., Serody, J.S., C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am. J. Pathol. 173 (2008), 253–264.
285. Varney, M.L., Olsen, K.J., Mosley, R.L., Singh, R.K., Paracrine regulation of vascular endothelial growth factor—a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J. Interferon Cytokine Res. 25 (2005), 674–683.
286. Vela, M., Aris, M., Llorente, M., Garcia-Sanz, J.A., Kremer, L., Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front. Immunol., 6, 2015, 12.
287. Velasco-Velazquez, M., Pestell, R.G., The CCL5/CCR5 axis promotes metastasis in basal breast cancer. OncoImmunology, 2, 2013, e23660.
288. Vesely, M.D., Kershaw, M.H., Schreiber, R.D., Smyth, M.J., Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29 (2011), 235–271.
289. Vila-Coro, A.J., Rodriguez-Frade, J.M., Martin De Ana, A., Moreno-Ortiz, M.C., Martinez, A.C., Mellado, M., The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13 (1999), 1699–1710.
290. Viola, A., Contento, R.L., Molon, B., T cells and their partners: the chemokine dating agency. Trends Immunol. 27 (2006), 421–427.
291. Von Hundelshausen, P., Koenen, R.R., Sack, M., Mause, S.F., Adriaens, W., Proudfoot, A.E., Hackeng, T.M., Weber, C., Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105 (2005), 924–930.
292. Vroon, A., Heijnen, C.J., Kavelaars, A., GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80 (2006), 1214–1221.
293. Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S.K., Dubois, R.N., CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203 (2006), 941–951.
294. Wang, J., Wang, J., Dai, J., Jung, Y., Wei, C.L., Wang, Y., Havens, A.M., Hogg, P.J., Keller, E.T., Pienta, K.J., Nor, J.E., Wang, C.Y., Taichman, R.S., A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res. 67 (2007), 149–159.
295. Wang, S.W., Liu, S.C., Sun, H.L., Huang, T.Y., Chan, C.H., Yang, C.Y., Yeh, H.I., Huang, Y.L., Chou, W.Y., Lin, Y.M., Tang, C.H., CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment. Carcinogenesis 36 (2015), 104–114.
296. Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., Wen, J., Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil. Int. J. Oncol. 48 (2016), 1341–1352.
297. Ward, S.T., Li, K.K., Hepburn, E., Weston, C.J., Curbishley, S.M., Reynolds, G.M., Hejmadi, R.K., Bicknell, R., Eksteen, B., Ismail, T., Rot, A., Adams, D.H., The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. Br. J. Cancer 112 (2015), 319–328.
298. Wendel, M., Galani, I.E., Suri-Payer, E., Cerwenka, A., Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res. 68 (2008), 8437–8445.
299. Weng, D., Penzner, J.H., Song, B., Koido, S., Calderwood, S.K., Gong, J., Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res., 14, 2012, R18.
300. White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Emson, P., Foord, S.M., Marshall, F.H., Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396 (1998), 679–682.
301. Witt, D.P., Lander, A.D., Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4 (1994), 394–400.
302. Wolf, M.J., Hoos, A., Bauer, J., Boettcher, S., Knust, M., Weber, A., Simonavicius, N., Schneider, C., Lang, M., Sturzl, M., Croner, R.S., Konrad, A., Manz, M.G., Moch, H., Aguzzi, A., Van Loo, G., Pasparakis, M., Prinz, M., Borsig, L., Heikenwalder, M., Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 22 (2012), 91–105.
303. Wong, M., Fish, E.N., RANTES and MIP-1alpha activate stats in T cells. J. Biol. Chem. 273 (1998), 309–314.
304. Wong, M., Uddin, S., Majchrzak, B., Huynh, T., Proudfoot, A.E., Platanias, L.C., Fish, E.N., Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J. Biol. Chem. 276 (2001), 11427–11431.
305. Wu, Y., Li, Y.Y., Matsushima, K., Baba, T., Mukaida, N., CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J. Immunol. 181 (2008), 6384–6393.
306. Wu, Y.C., Tang, S.J., Sun, G.H., Sun, K.H., CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer. Oncogene 35 (2016), 2123–2132.
307. Wysoczynski, M., Reca, R., Ratajczak, J., Kucia, M., Shirvaikar, N., Honczarenko, M., Mills, M., Wanzeck, J., Janowska-Wieczorek, A., Ratajczak, M.Z., Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 105 (2005), 40–48.
308. Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T., Saijo, Y., Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25 (2007), 1618–1626.
309. Yamada, K., Maishi, N., Akiyama, K., Towfik Alam, M., Ohga, N., Kawamoto, T., Shindoh, M., Takahashi, N., Kamiyama, T., Hida, Y., Taketomi, A., Hida, K., CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property. Int. J. Cancer 137 (2015), 2825–2836.
310. Yang, P., Li, Q.J., Feng, Y., Zhang, Y., Markowitz, G.J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., Wang, H.Y., Cheng, S.Q., Xie, D., Wang, X.F., TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22 (2012), 291–303.
311. Yeudall, W.A., Vaughan, C.A., Miyazaki, H., Ramamoorthy, M., Choi, M.Y., Chapman, C.G., Wang, H., Black, E., Bulysheva, A.A., Deb, S.P., Windle, B., Deb, S., Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration. Carcinogenesis 33 (2012), 442–451.
312. Yu, Y., Sweeney, M.D., Saad, O.M., Crown, S.E., Hsu, A.R., Handel, T.M., Leary, J.A., Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280 (2005), 32200–32208.
313. Yu, Y.R., Fong, A.M., Combadiere, C., Gao, J.L., Murphy, P.M., Patel, D.D., Defective antitumor responses in CX3CR1-deficient mice. Int. J. Cancer 121 (2007), 316–322.
314. Zavadil, J., Cermak, L., Soto-Nieves, N., Bottinger, E.P., Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23 (2004), 1155–1165.
315. Zeelenberg, I.S., Ruuls-Van Stalle, L., Roos, E., The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63 (2003), 3833–3839.
316. Zeng, Y.J., Lai, W., Wu, H., Liu, L., Xu, H.Y., Wang, J., Chu, Z.H., Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer. Oncotarget 7 (2016), 27394–27407, 10.18632/oncotarget.8423.
317. Zhang, X.F., Wang, J.F., Matczak, E., Proper, J.A., Groopman, J.E., Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 97 (2001), 3342–3348.
318. Zhang, X., Liu, X., Shang, H., Xu, Y., Qian, M., Monocyte chemoattractant protein-1 induces endothelial cell apoptosis in vitro through a p53-dependent mitochondrial pathway. Acta Biochim. Biophys. Sin. (Shanghai) 43 (2011), 787–795.
319. Zhang, Y., Yang, P., Sun, T., Li, D., Xu, X., Rui, Y., Li, C., Chong, M., Ibrahim, T., Mercatali, L., Amadori, D., Lu, X., Xie, D., Li, Q.J., Wang, X.F., miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat. Cell Biol. 15 (2013), 284–294.
320. Zhang, J., Zhou, Y., Yang, Y., CCR7 pathway induces epithelial-mesenchymal transition through up-regulation of Snail signaling in gastric cancer. Med. Oncol., 32, 2015, 467.
321. Zhou, S., Chen, L., Qin, J., Li, R., Tao, H., Zhen, Z., Chen, H., Chen, G., Yang, Y., Liu, B., She, Z., Zhong, C., Liang, C., Depletion of CD4 + CD25 + regulatory T cells promotes CCL21-mediated antitumor immunity. PLoS One, 8, 2013, e73952.
322. Zhou, J., Xiang, Y., Yoshimura, T., Chen, K., Gong, W., Huang, J., Zhou, Y., Yao, X., Bian, X., Wang, J.M., The role of chemoattractant receptors in shaping the tumor microenvironment. Biomed. Res. Int., 2014, 2014, 751392.
323. Zhou, S.L., Zhou, Z.J., Hu, Z.Q., Li, X., Huang, X.W., Wang, Z., Fan, J., Dai, Z., Zhou, J., CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3beta/Snail signaling. Cancer Lett. 358 (2015), 124–135.
324. Zimmermann, T., Moehler, M., Gockel, I., Sgourakis, G.G., Biesterfeld, S., Muller, M., Berger, M.R., Lang, H., Galle, P.R., Schimanski, C.C., Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8 + T-cell infiltration. Int. J. Colorectal Dis. 25 (2010), 417–424.
325. Zlotnik, A., Burkhardt, A.M., Homey, B., Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol. 11 (2011), 597–606.
326. Zou, W., Borvak, J., Marches, F., Wei, S., Galanaud, P., Emilie, D., Curiel, T.J., Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J. Immunol. 165 (2000), 4388–4396.
327. Zumwalt, T.J., Arnold, M., Goel, A., Boland, C.R., Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB + CD8 + T-cell infiltration. Oncotarget 6 (2015), 2981–2991.